BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3708040)

  • 1. Efficacy of phenelzine in geriatric depression.
    Lazarus LW; Groves L; Gierl B; Pandey G; Javaid JI; Lesser J; Ha YS; Davis J
    Biol Psychiatry; 1986 Jun; 21(7):699-701. PubMed ID: 3708040
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mania associated with high percentage of inhibition of monoamine oxidase.
    Bowden CL; Seleshi E; Javors MA
    Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW; Harrison W; Cooper TB; Quitkin FM
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW; Waller DA; Orsulak PJ
    Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to phenelzine and subsequent refractory depression: three cases.
    Donaldson SR
    J Clin Psychiatry; 1989 Jan; 50(1):33-5. PubMed ID: 2910838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
    Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibitor-induced speech blockage.
    Goldstein DM; Goldberg RL
    J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse of monoamine oxidase inhibitors.
    Baumbacher G; Hansen MS
    Am J Drug Alcohol Abuse; 1992; 18(4):399-406. PubMed ID: 1449122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.